Skip to main content
15/11/2023

Two VHIR and Cemcat researchers among the most cited in 2023 according to Clarivate

Laboratori

Research lab

15/11/2023

The list identifies the most influential experts, who are among the 1% most cited in their speciality in several areas of knowledge.

On Wednesday 15 November, Clarivate Analytics published the list of the most cited scientists in 2023. This is one of the most prestigious rankings among the international academic and scientific community that once again this year has the presence of professionals from the Vall d'Hebron Research Institute (VHIR) and the Multiple Sclerosis Centre of Catalonia (Cemcat).

In the category of Neurosciences and Behaviour, Dr. Xavier Montalban, head of the Neurology Service at Vall d'Hebron University Hospital, head of the Clinical Neuroimmunology research group at VHIR and director of Cemcat, and Dr. Mar Tintoré, clinical head of the Neurology Service at Vall d'Hebron University Hospital, principal investigator at the Clinical Neuroimmunology research group at VHIR and head of healthcare at Cemcat.

Clarivate list of most highly cited researchers

Determined by the Clarivate team, the list includes selected researchers who have written multiple highly cited articles that rank in the top 1% of the most cited articles per field and per year in Web of Science over the last decade. This is not the only selection indicator. A preliminary list based on citation activity is then refined through qualitative analysis and expert judgement.

This year's Highly Cited Researcher designations have been awarded to 7,125 individuals. This small fraction of the research population contributes significantly to pushing the frontiers of knowledge and achieving innovative solutions to make the world healthier, more sustainable and safer.

The full list of highly cited researchers in 2023 can be found here.

Related news

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Mar Tintore Subirana

Mar Tintore Subirana

Main researcher
Clinical Neuroimmunology
Read more
Margarida Capell Maymo

Margarida Capell Maymo

Administration and Management
Clinical Neuroimmunology
Read more
M Jesus Arevalo  Navines

M Jesus Arevalo Navines

Postdoctoral researcher
Clinical Neuroimmunology
Read more
Joaquin Castillo Justribo

Joaquin Castillo Justribo

Postdoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.